There are 2934 resources available
Rationale for, and an orientation to, immunotherapy
Presenter: Lana Kandalaft
Session: Update on novel therapies in ovarian cancer
Resources:
Slides
Webcast
Results of immunotherapy trials in ovarian cancer: Where do we stand in 2019?
Presenter: Antonio González Martín
Session: Update on novel therapies in ovarian cancer
Resources:
Slides
Webcast
Where do we stand with PARP inhibitors in ovarian cancer treatment in 2019?
Presenter: Jonathan Ledermann
Session: Update on novel therapies in ovarian cancer
Resources:
Slides
Webcast
Do we already have biomarkers that may predict response and/or resistance to PARP inhibitors?
Presenter: Charlie Gourley
Session: Update on novel therapies in ovarian cancer
Resources:
Slides
Webcast
The clinical utility of multigene sequencing in metastatic breast cancer
Presenter: Monica Arnedos
Session: Where will future technologies take us in metastatic breast cancer?
Resources:
Slides
Webcast
The role of Artificial Intelligence (AI)
Presenter: Nikos Paragios
Session: Where will future technologies take us in metastatic breast cancer?
Resources:
Slides
Webcast
Does radiotherapy still have a role in stage III NSCLC in the era of immunotherapy? The radiotherapist’s view
Presenter: Kevin Franks
Session: Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Resources:
Slides
Webcast
Where is immunotherapy for small cell lung cancer and mesothelioma now?
Presenter: Alessandra Curioni
Session: Immunotherapy in thoracic malignancies: What has been achieved in 2019?
Resources:
Slides
Webcast
Where are we with liquid biopsies in breast cancer?
Presenter: Nicholas Turner
Session: Where will future technologies take us in metastatic breast cancer?
Resources:
Slides
Webcast
3857 - Phase II Study of Pertuzumab and Trastuzumab-emtansine (T-DM1) in Patients with HER2-positive Metastatic Colorectal Cancer: the HERACLES-B (HER2 Amplification for Colo-rectaL cancer Enhanced Stratification, cohort B) Trial
Presenter: Andrea Sartore-Bianchi
Session: Poster Discussion – Gastrointestinal tumours, colorectal
Resources:
Abstract